Fore Biotherapeutics

fore.bio
3675 Market Street Suite 200
Philadelphia, PA 19104

Company Info

Year Established
2011

Contacts

William Hinshaw
CEO

Michael Byrnes
CFO

Company Description

Fore is a registration stage targeted oncology company dedicated to developing innovative treatments that provide better outcomes for patients with the hardest-to-treat cancers.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.